• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Tetraphase Pharmaceuticals, Inc. (TTPH)

    -NasdaqGS
    47.88 0.00(0.00%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 9,098   10,486   7,600  
    Cost of Revenue -   -   -  
    Gross Profit 9,098   10,486   7,600  
    Operating Expenses
    Research Development61,932  31,508  17,294  
    Selling General and Administrative12,932  7,168  4,309  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (65,766) (28,190) (14,003)
    Income from Continuing Operations
    Total Other Income/Expenses Net41  273  (63)
    Earnings Before Interest And Taxes(65,725)(27,917)(14,066)
    Interest Expense1,017  1,719  1,021  
    Income Before Tax(66,742)(29,636)(15,087)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(66,742)(29,636)(15,087)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (66,742) (29,636) (15,087)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (66,742) (29,636) (15,087)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.